Sweden· SE-19931203000079
Ansatipin 150 mg Kapsel, hård
A medicinal product containing rifabutin, registered in Sweden by Pfizer AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Rifabutin
- Manufacturer
- Pfizer AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19931203000079
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rifabutin in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesRifabutinREMEDYREPACK INC.
- FinlandAnsatipinPfizer Oy
- NorwayAnsatipinSERB
- United KingdomMycobutin 150mg capsulesPfizer Ltd
- SpainANSATIPIN 150 MG CÁPSULAS DURASBinesa 2002 S.L.
- BelgiumMycobutin 150 mgPfizer
- IrelandMycobutin 150mg Hard CapsulesPfizer Healthcare Ireland Unlimited Company
- NetherlandsMycobutin, capsules 150 mgPfizer B.V.
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Mycobutin
- Belgium · Mycobutin
- Czechia · Mycobutin
- Germany · Mycobutin
- Spain · Ansatipin
- Finland · Ansatipin
- France · Ansatipine
- United Kingdom (Northern Ireland) · Mycobutin, Rifabutin Pfizer
- Ireland · Mycobutin
- Italy · Mycobutin
- Luxembourg · Mycobutin
- Netherlands · Mycobutin
- Portugal · Mycobutin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8b9c36b0-26f3-4f16-9955-d006c2b69a7f GET /v1/drugs/8b9c36b0-26f3-4f16-9955-d006c2b69a7f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL",
"Dispensbeslut"
],
"se_npl_id": "19931203000079",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19931203000079",
"product_doc_link": "https://docetp.mpa.se/LMF/Ansatipin%20capsule%2C%20hard%20SmPC_09001bee807a2fff.pdf"
}See everything about rifabutin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.